Insights

Dr Strong, from Northwestern Medicine in Chicago, reviews the key points of his lecture on the need for a team approach to perianal Crohn disease from the July 23 AIBD conference.

Dr Cohen discusses his talk on managing infections such as cytomegalovirus and histoplasmosis among patients with IBD, and testing for tuberculosis before starting immunosuppressive therapy.

Dr Rubin, from the University of Chicago, discusses how using a treat to target approach can enhance patient quality of life, achieve tight control of inflammatory bowel disease, and ensure optimal outcomes.

Dr Charabaty, from Johns Hopkins University School of Medicine, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting in Chicago on the key steps for managing the patient with acute severe ulcerative...

Dr Regueiro, from Cleveland Clinic and chair of the AIBD regional meeting in Chicago, provides an overview of the faculty and topics that will be featured.

In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.

In this episode of IBD Drive Time, your hosts Drs Ray Cross and Millie Long discuss the best abstracts from Digestive Disease Week 2022 with Dr Dave Hudesman.

Dr Horst, from Vanderbilt University Medical Center, reviews the key points of her presentation from Digestive Disease Week 2022 on treatment options for patients with ulcerative colitis for whom multiple biologic treatments have failed.